By Shannon Henson ( July 15, 2009, 12:00 AM EDT) -- In a settlement, Merck & Co. and Schering-Plough Corp. have agreed to reimburse 35 states and the District of Columbia for the costs associated with investigating a delay in the companies' release of negative results of a clinical trial of the jointly marketed cholesterol treatment Vytorin....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.